GPCM
Granite Point Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-8,000
| Closed | -$1.22M | – | 81 |
|
2019
Q2 | $1.22M | Sell |
8,000
-12,500
| -61% | -$1.9M | 0.08% | 34 |
|
2019
Q1 | $2.44M | Hold |
20,500
| – | – | 0.24% | 22 |
|
2018
Q4 | $2.24M | Hold |
20,500
| – | – | 0.45% | 16 |
|
2018
Q3 | $3.31M | Sell |
20,500
-7,220
| -26% | -$1.17M | 0.22% | 19 |
|
2018
Q2 | $3.66M | Sell |
27,720
-3,300
| -11% | -$436K | 0.33% | 16 |
|
2018
Q1 | $2.3M | Sell |
31,020
-13,200
| -30% | -$978K | 0.22% | 21 |
|
2017
Q4 | $2.46M | Sell |
44,220
-2,300
| -5% | -$128K | 0.24% | 21 |
|
2017
Q3 | $2.11M | Sell |
46,520
-16,700
| -26% | -$757K | 0.44% | 23 |
|
2017
Q2 | $2.13M | Buy |
63,220
+39,850
| +171% | +$1.34M | 0.53% | 26 |
|
2017
Q1 | $692K | Sell |
23,370
-36,630
| -61% | -$1.08M | 0.21% | 49 |
|
2016
Q4 | $1.65M | Sell |
60,000
-100,000
| -63% | -$2.74M | 1.31% | 22 |
|
2016
Q3 | $9.83M | Buy |
160,000
+45,000
| +39% | +$2.76M | 3.84% | 1 |
|
2016
Q2 | $2.19M | Buy |
+115,000
| New | +$2.19M | 0.94% | 14 |
|